Ethic Inc’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.31M | Sell |
92,144
-72,989
| -44% | -$5M | 0.11% | 187 |
|
|
2025
Q1 | $11.2M | Sell |
165,133
-6,489
| -4% | -$441K | 0.23% | 91 |
|
|
2024
Q4 | $14.8M | Buy |
171,622
+3,805
| +2% | +$327K | 0.3% | 52 |
|
|
2024
Q3 | $21.5M | Sell |
167,817
-13,677
| -8% | -$1.76M | 0.54% | 20 |
|
|
2024
Q2 | $25.9M | Buy |
181,494
+13,677
| +8% | +$1.95M | 0.61% | 16 |
|
|
2024
Q1 | $21.5M | Buy |
167,817
+1,444
| +0.9% | +$185K | 0.54% | 20 |
|
|
2023
Q4 | $17.2M | Buy |
166,373
+7,556
| +5% | +$782K | 0.51% | 24 |
|
|
2023
Q3 | $14.4M | Buy |
158,817
+20,773
| +15% | +$1.89M | 0.51% | 25 |
|
|
2023
Q2 | $11.2M | Buy |
138,044
+1,284
| +0.9% | +$104K | 0.41% | 35 |
|
|
2023
Q1 | $10.9M | Sell |
136,760
-6,406
| -4% | -$510K | 0.44% | 35 |
|
|
2022
Q4 | $9.69M | Buy |
143,166
+18,374
| +15% | +$1.24M | 0.52% | 28 |
|
|
2022
Q3 | $6.22M | Buy |
124,792
+37,218
| +42% | +$1.85M | 0.42% | 37 |
|
|
2022
Q2 | $4.88M | Buy |
87,574
+10,608
| +14% | +$591K | 0.34% | 61 |
|
|
2022
Q1 | $4.27M | Buy |
76,966
+25,774
| +50% | +$1.43M | 0.3% | 80 |
|
|
2021
Q4 | $2.87M | Buy |
51,192
+5,898
| +13% | +$330K | 0.22% | 113 |
|
|
2021
Q3 | $2.17M | Buy |
45,294
+9,252
| +26% | +$444K | 0.22% | 117 |
|
|
2021
Q2 | $1.51M | Buy |
36,042
+6,046
| +20% | +$253K | 0.18% | 140 |
|
|
2021
Q1 | $1.01M | Buy |
29,996
+236
| +0.8% | +$7.95K | 0.18% | 154 |
|
|
2020
Q4 | $1.04M | Buy |
29,760
+410
| +1% | +$14.3K | 0.27% | 87 |
|
|
2020
Q3 | $1.02M | Buy |
29,350
+9,900
| +51% | +$344K | 0.39% | 57 |
|
|
2020
Q2 | $637K | Buy |
19,450
+1,910
| +11% | +$62.6K | 0.36% | 69 |
|
|
2020
Q1 | $528K | Buy |
17,540
+3,860
| +28% | +$116K | 0.44% | 70 |
|
|
2019
Q4 | $396K | Buy |
+13,680
| New | +$396K | 0.29% | 114 |
|